Title

Final results of a phase I study of Y-90-ibritumomab-tiuxetan (Y-90-IT) in children with recurrent/refractory CD20 positive lymphoma: A COG phase I consortium study

Document Type

Journal Article

Publication Date

2006

Journal

Cancer Biotherapy and Radiopharmaceuticals

Volume

21

Issue

4

Inclusive Pages

394-395

This document is currently not available here.

Share

COinS